Really exciting to see the clinical culmination of your group’s earlier observations on BET inhibition potentiating JAK inhibitors in inflammation suppression in MF. Valuable clinical efficacy data in a disease where combination therapies are challenging.

Thank you Dr Grant for an insightful discussion on the multilevel barriers to stem cell transplant, highlighting the sobering statistics of persistent disparities and policy level changes that are needed to ensure equitable access to this key arm of leukemia therapy.

HbSS outcomes in LMIC, tolerability of novel agents in URMs and neighborhood effects on leukemia-outstanding talks by the Hematology Inclusion Pathway trainees. Great discussion by alumni and mentors #ASH24 @UICDom @UICancerCenter

Thank you for your efforts in leading this innovative work @Anand_88_Patel and @andrewthepalmer !

So excited for the event co-hosted by @LeeGrimesLab with the most amazing people coming from across the country to share their science! @Irumkhan_hem @jjplascak #AndrewHantel #GustavoRivero @MariaAmaya_27 @Bailee_Kain @IsaiahKBoateng @OSUCCC_James - hope to see everyone there!!!

Fantastic line up @btfoundation #SCHD24 1-valuable trial implementation lesson from early covid trials to account for slower rate of BIPOC accrual due to access issues 2-effective communication around gender identity, race and ethnicity is first step to a therapeutic alliance

Incredible talk by Dr. Michele Andrasik about unpacking #disparities to inform action at #SCHD24 @btfoundation - take note of these key messages and remember that all our #meded learners need to be taught about disparities!

#SCHD24 call for abstracts in the following categories: ▶️Basic science research ▶️Clinical research ▶️Quality-of-care research ▶️Outcomes research ▶️Case reports and case-series https://t.co/haEHV6spmy This annual meeting is one of the largest gatherings of cancer care

A prospective approach linking individual level pt reported SDOH data to early adverse AML outcomes. Proud of @EshanaShahMD for an excellent oral abstract and the dedicated efforts of leukemia teams, trainees and patients @UICancerCenter and @LurieCancer

Congratulations! Linking macroenvironment to cancer outcomes is so challenging. thank you for sharing! I am going to town with my highlighter 😀…

Honored to continue our teamwork to establish a link between social and physical environment and #AML biology and outcomes. @Anand_88_Patel @UChicagoLeuk @cgalve8 @UICancerCenter Dr. Tsai @LoyolaOnc @jaltmanmd @LurieCancer Dr. Larson @RushCancer & Dr. Zia @CookCountyIMR

Exciting collab w DrTyner ⁦@OHSUKnight⁩ and ⁦⁩ ⁦@UICancerCenter⁩ leveraging BeatAML data to show FOXM1 underlies chemosensitivty in NPM1mut AML and investigating a novel FOXM1 inhibitor ⁦@ACS_Research⁩ ⁦⁦⁦@LurieCancer⁩

Important work showing us that dogmatic clinical trial eligibility criteria need to be individually re-examined in the interest of inclusivity. Thank you @ahantel for including us.

Looking forward to a great exchange of practice points and experiences in managing myeloid malignancies from a global oncology perspective. @LurieCancer @ACS_Research

It’s finally here! 🥹 https://t.co/28m7c3k81j Thanks to my collaborators @abhinrl @LuskinMarlise @ColemanLindsley @c_j_gibson @jaiswalmdphd @AlexBickMDPhD @pnatarajanmd @DrFlashHeart Luca Malcovati, Donna Neuberg, Waihay Wong, Rich Stone, Dan DeAngelo and of course Ben Ebert

Thanks @JazzPharma for sponsoring the inaugural Women in Leukemia event! And thank you to the women AND men who came out in support! @EuniceWangMD @AmyDeZern @beatalleukemia @Geoff_Uy

Fascinating animal data from @profshanecrotty that unbeknownst to us, memory b cells are training to become 1000 fold more potent against antigenic variants in germinal center arsenals upto 6 months after vaccine exposure #ASH2022

Thats over 10 years of @AKUGlobal alumni in that picture! thank you for bringing us together and look forward to growing the group in years to come. #ASH22

Abst 0933 Multiomic single cell analysis of ven-gilt aml treated pts suggests all RAS mut were present at v low levels at diagnosis in cells containing FLT3 mut. So expansion shaped by therapy AND inc expression of monocytic surf markers w treatment #ASH22 #leusm @vekennedy

Just finished facilitating the #ASH22 #healthequity studio with @Irumkhan_hem on recognizing and addressing #ImplicitBias. Actions: be aware of yours, speak up when you see it, ask about SDH, use inclusive language (in charts too).